Contents
The sub-variant BA.5 is closely watched by scientists and doctors. “The disease is slightly different because the virus has changed,” said immunologist Prof. Luke O’Neill. And while the new mutation most often shows similar symptoms to the previous ones, experts point out one distinct change. It is possible that thanks to it, we will have an intranasal COVID-19 vaccine in the future.
- The symptoms of a BA.5 mutation often resemble a cold or upper respiratory infection
- The symptoms include: fever, sneezing, headache, intense night sweats, sore throat
- To what extent have subsequent mutations changed the symptoms of coronavirus infection? Dr. Allison Arwady: There are no really significant differences except we have more upper respiratory symptoms
- More current information can be found on the Onet homepage.
Symptoms of infection with sub-variant BA.5
New Omicron BA.4 sub-variants, especially BA.5, are spreading around the world, triggering another wave of the COVID-19 pandemic. The observations so far show that the symptoms caused by these mutations often resemble a cold or upper respiratory tract infections.
Symptoms include elevated body temperature or fever, sore throat, stuffy nose, runny nose, cough, sneezing, headache, weakness, malaise, muscle aches and joint pain. Doctors also note intense night sweats and a sore throat. There is also information about the growing number of cases of loss of smell (so far based only on the observations of doctors).
Many scientists and doctors, when observing the symptoms appear, wonder if they change with each variant of the coronavirus. There are first conclusions about this.
The rest of the article under the video.
According to the University of California Medical Center, Davis, reported BA.5 symptoms are similar to previous COVID-19 variants. At this point, therefore, it seems that there is no difference in symptoms observed in BA.4 or BA.5 and previous Omicron subvariants.
Fast antigen for presence virus SARS-CoV-2 You can find a nasal swab at home at Medonet Market.
The commissioner of the city’s Public Health Department has a similar opinion. Dr. Allison Arwady admitted that although we have newer variants of SARS-CoV-2, the symptoms remain similar to previous cases. With one notable change. «There are no really significant differences except we have more symptoms. It’s a more virulent infection » Dr. Arwady said.
According to her, the variants tend to stay not in the lungs, but in the nasal passage. This change could lead to the development of an intranasal COVID-19 vaccine in the future.
We encourage you to listen to the latest episode of the RESET podcast. This time Kamila Wykrota, the resilience trainer, will tell us about what resilience is. How does the ability to adapt to changing circumstances and react to adversities affect our quality of life? You will find out by listening to the latest episode of our podcast.